Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer.
作者信息
Untaru Rossana, Chen Dongqing, Kelly Conagh, May Austin, Collins Nicholas J, Leitch James, Attia John R, Proeitto Anthony M, Boyle Andrew J, Sverdlov Aaron L, Ngo Doan T M
出版信息
JACC CardioOncol. 2020 Jun 16;2(2):312-315. doi: 10.1016/j.jaccao.2020.05.010. eCollection 2020 Jun.
Abstract
摘要
相似文献
1
Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer.癌症病史患者心脏保护药物的使用未达最佳状态。
JACC CardioOncol. 2020 Jun 16;2(2):312-315. doi: 10.1016/j.jaccao.2020.05.010. eCollection 2020 Jun.
2
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency.慢性肾功能不全患者的心脏危险因素及心脏保护药物的使用
Am J Kidney Dis. 2001 Mar;37(3):484-9.
3
Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.错失的机会：尽管下肢外周动脉疾病患者中心脏保护药物的使用有所改善，但仍存在使用率不足的情况。
Circulation. 2012 Sep 11;126(11):1345-54. doi: 10.1161/CIRCULATIONAHA.112.108787. Epub 2012 Aug 8.
4
Antiretroviral therapy and cardiovascular risk: are some medications cardioprotective?抗逆转录病毒疗法与心血管风险：某些药物具有心脏保护作用吗？
Curr Opin HIV AIDS. 2008 May;3(3):226-33. doi: 10.1097/COH.0b013e3282f6451a.
5
Cardioprotective medication use after renal transplantation.肾移植后心脏保护性药物的使用。
Clin Transplant. 2010 Nov-Dec;24(6):E253-6. doi: 10.1111/j.1399-0012.2010.01297.x.
6
Cardioprotective interventions for cancer patients receiving anthracyclines.针对接受蒽环类药物治疗的癌症患者的心脏保护干预措施。
Cochrane Database Syst Rev. 2005 Jan 25(1):CD003917. doi: 10.1002/14651858.CD003917.pub2.
7
Cardioprotective interventions for cancer patients receiving anthracyclines.针对接受蒽环类药物治疗的癌症患者的心脏保护干预措施。
Cochrane Database Syst Rev. 2008 Apr 16(2):CD003917. doi: 10.1002/14651858.CD003917.pub3.
8
9
Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?心脏药物及其与新发透析患者心血管事件的关联：因果关系？
Kidney Int. 2004 Mar;65(3):1017-25. doi: 10.1111/j.1523-1755.2004.00473.x.
10
Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Psychotic Disorders: A Population-Based Cohort Study.精神障碍患者急性冠状动脉综合征后死亡率、血运重建和心脏保护药物治疗：一项基于人群的队列研究。
Schizophr Bull. 2020 Jul 8;46(4):774-784. doi: 10.1093/schbul/sbaa013.
引用本文的文献
1
Cardiovascular Medication and Health Service Use in Individuals With Cancer: A Retrospective Population-Based Cohort Study.癌症患者的心血管药物使用与医疗服务利用：一项基于人群的回顾性队列研究。
Cancer Med. 2025 May;14(9):e70911. doi: 10.1002/cam4.70911.
2
Atherosclerotic Cardiovascular Disease in Cancer Survivors: Current Evidence, Risk Prediction, Prevention, and Management.癌症幸存者的动脉粥样硬化性心血管疾病：当前证据、风险预测、预防与管理
J Lipid Atheroscler. 2025 Jan;14(1):30-39. doi: 10.12997/jla.2025.14.1.30. Epub 2024 Jul 19.
3
Cardiovascular disease and lung cancer.心血管疾病和肺癌。
Front Oncol. 2024 Feb 12;14:1258991. doi: 10.3389/fonc.2024.1258991. eCollection 2024.
4
Simplified rules-based tool to facilitate the application of up-to-date management recommendations in cardio-oncology.基于规则的简化工具，以促进最新心脏肿瘤学管理建议的应用。
Cardiooncology. 2023 Oct 27;9(1):37. doi: 10.1186/s40959-023-00179-w.
5
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer.心血管合并症对贝伐珠单抗治疗老年转移性结直肠癌有效性和安全性的影响。
Target Oncol. 2023 Sep;18(5):717-726. doi: 10.1007/s11523-023-00986-2. Epub 2023 Sep 8.
6
Comparison of cardiovascular disease risk in women with and without breast cancer: secondary data analysis with the 2014-2018 korean national health and nutrition examination survey.比较有和无乳腺癌女性的心血管疾病风险：基于 2014-2018 年韩国国家健康和营养检查调查的二次数据分析。
BMC Public Health. 2023 Jun 15;23(1):1158. doi: 10.1186/s12889-023-16063-2.
7
Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design.患者相似性及其他人工智能机器学习算法在预防心血管毒性（PACT）共同决策临床决策辅助中的应用：一项可行性试验设计
Cardiooncology. 2023 Jan 23;9(1):7. doi: 10.1186/s40959-022-00151-0.
8
The Importance of Primary Care in Cardio-Oncology.初级保健在心肿瘤学中的重要性。
Curr Treat Options Oncol. 2021 Oct 21;22(12):107. doi: 10.1007/s11864-021-00908-2.
9
Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab.接受贝伐单抗治疗的癌症患者发生不良心血管事件的相关因素。
J Clin Med. 2020 Aug 18;9(8):2664. doi: 10.3390/jcm9082664.
本文引用的文献
1
Treatment of patients with myocardial infarction depends on history of cancer.心肌梗死患者的治疗取决于癌症史。
Eur Heart J Acute Cardiovasc Care. 2018 Oct;7(7):639-645. doi: 10.1177/2048872617729636. Epub 2017 Sep 19.
2
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.癌症患者及癌症幸存者的心血管健康：迈向新高度的路线图。
J Am Coll Cardiol. 2015 Jun 30;65(25):2739-46. doi: 10.1016/j.jacc.2015.04.059.
3
Appropriateness of cardiovascular care in elderly adult cancer survivors.老年癌症幸存者的心血管保健适宜性。
Med Oncol. 2013;30(2):561. doi: 10.1007/s12032-013-0561-4. Epub 2013 Apr 6.
4
Chronic health conditions in adult survivors of childhood cancer.儿童癌症成年幸存者的慢性健康状况。
N Engl J Med. 2006 Oct 12;355(15):1572-82. doi: 10.1056/NEJMsa060185.
Zotero 插件